Reviewing the Impact of Powder Cohesion on Continuous Direct Compression (CDC) Performance

Abstract

The pharmaceutical industry is undergoing a paradigm shift towards continuous processing from batch, where continuous direct compression (CDC) is considered to offer the most straightforward implementation amongst powder processes due to the relatively low number of unit operations or handling steps. Due to the nature of continuous processing, the bulk properties of the formulation will require sufficient flowability and tabletability in order to be processed and transported effectively to and from each unit operation. Powder cohesion presents one of the greatest obstacles to the CDC process as it inhibits powder flow. As a result, there have been many studies investigating potential manners in which to overcome the effects of cohesion with, to date, little consideration of how these controls may affect downstream unit operations. The aim of this literature review is to explore and consolidate this literature, considering the impact of powder cohesion and cohesion control measures on the three-unit operations of the CDC process (feeding, mixing, and tabletting). This review will also cover the consequences of implementing such control measures whilst highlighting subject matter which could be of value for future research to better understand how to manage cohesive powders for CDC manufacture.

Chitosan alchemy: transforming tissue engineering and wound healing

“…Malfunctioning of any kind may lead to unstable products and batches with significant variability. 209 Regulatory agencies regulate a therapeutic product's safety and desired response while eliminating its harmful and undesired effects. CS, which comes from animal sources, should undergo rigorous microbial tests to remove animal-borne contamination.…”

Using Chia Powder as a Binder to Obtain Chewable Tablets Containing Quinoa for Dietary Fiber Supplementation

“…For a tablet formulation to have adequate compressibility and compactability, the flow must not negatively impact the process. In this sense, a critical attribute is the cohesion of the formulation, which is significant in the manufacturing process of any solid pharmaceutical form [36,39]. When the flow of a material is considered suitable for formulation development, it means that in the compressibility stage, the particles will have an affinity to adhere to each other, mainly due to the size and shape of the particles [36,40].…”

Use of Chia as a Binder to Obtain Chewable Tablets Containing Quinoa for Dietary Fiber Supplementation

“…For a tablet formulation to have adequate compressibility and compactability, the flow mustn't negatively impact the process. In this sense, an essential critical attribute is the cohesion of the formulation, considered significant in the manufacturing process of any solid pharmaceutical form [30,33]). When the flow of a material is considered suitable for formulation development, it means that in the compressibility stage, the particles will have an affinity to adhere to each other, mainly due to the size and shape of the particles being one of the factors that most contribute to this behavior [30,34].…”